SpringWorks jumps as Merck KGaA reportedly nears $3.5B buyout deal
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 24 2025
0mins
Source: SeekingAlpha
Merck KGaA's Acquisition of SpringWorks: Merck KGaA is nearing a $3.5 billion deal to acquire SpringWorks Therapeutics, with an agreed per-share price close to $47, and the deal could close as early as Monday if no issues arise.
Market Reaction and Company Response: Following reports of the acquisition discussions, SpringWorks shares surged in February but have since declined by approximately 9% over the past month, with the company refraining from comments and canceling participation in an investor conference amid ongoing market speculation.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
